n/a
Abstract Title:

Anti-leukemia activities of selenium nanoparticles embedded in nanotube consisted of triple-helixβ-d-glucan.

Abstract Source:

Carbohydr Polym. 2020 Jul 15 ;240:116329. Epub 2020 Apr 23. PMID: 32475588

Abstract Author(s):

Yanxia Jin, Liqin Cai, Qian Yang, Ziyi Luo, Li Liang, Yuxing Liang, Balu Wu, Lu Ding, Dongdong Zhang, Xiaojuan Xu, Lina Zhang, Fuling Zhou

Article Affiliation:

Yanxia Jin

Abstract:

Acute myeloid leukemia (AML) is a difficult therapeutic hematological tumor. It is urgent to find a non-toxic natural drug to treat AML. Herein, the selenium nanoparticles (SeNPs) embedded in nanotubes consisted of triple helixβ-(1, 3)-d-glucan (BFP) from the black fungus that were wrapped to form stable inclusion complex BFP-Se, which was self-assembled and exhibited high stability in water. In vitro, the BFP-Se significantly inhibited the proliferation of AML cells and increased the cytotoxicity on AML cells. On single-cell levels, the U937 cells were gradually swelled and lysed with BFP-Se treatment on optofluidics chips. Further, the blood and bone marrow analysis indicated the anti-leukemia effects of BFP-Se in vivo. Moreover, BFP-Se increased the total antioxidant capacity of AML cells and decreased the expression of c-Jun activation domain-binding protein 1 and thioredoxin 1. Our results suggest that this biocompatible polysaccharide nanotube containing Se nanoparticles would provide a novel strategy for AML therapy.

Study Type : Animal Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.